Henry Schein Inc. Reaches New 12-Month High at $116.73 (HSIC)
Henry Schein (NASDAQ:HSIC)’s share price reached a new 52-week high during mid-day trading on Wednesday, Analyst Ratings Network reports. The stock traded as high as $116.73 and last traded at $116.53, with a volume of 212,610 shares traded. The stock had previously closed at $115.32.
Several analysts have recently commented on the stock. Analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note to investors on Friday, December 13th. They now have a $117.00 price target on the stock. Analysts at ISI Group raised their price target on shares of Henry Schein from $106.00 to $110.00 in a research note to investors on Monday, October 14th. They now have a “neutral” rating on the stock. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the company. Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $97.14.
Henry Schein has a one year low of $82.11 and a one year high of $116.07. The stock has a 50-day moving average of $113.6 and a 200-day moving average of $107.1. The company has a market cap of $10.067 billion and a price-to-earnings ratio of 24.26.
Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.01. The company had revenue of $2.30 billion for the quarter, compared to the consensus estimate of $2.37 billion. During the same quarter in the previous year, the company posted $1.08 earnings per share. The company’s revenue for the quarter was up 5.3% on a year-over-year basis. On average, analysts predict that Henry Schein will post $4.90 earnings per share for the current fiscal year.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.